OCRF- Super Luncheons


September is ovarian cancer awareness month. To mark the occasion, the Ovarian Cancer Research Fund will host lunches at Governors' mansions and designated event spaces throughout the nation. First Ladies and Governors will participate in the Super Luncheon program. As our distinguished guest, you will hear a leading oncologist speak, meet those battling the disease, ovarian cancer survivors, community leaders, and other supporters like yourself.

2nd Annual " Teal Tuesday" September 15th, 2009


2nd Annual " Teal Tuesday" 3rd Tuesday of September.
THINK TEAL, TALK TEAL, WEAR TEAL ~ SAVE LIVES. Tuesday, September 15th, 2009. "NATIONAL OVARIAN CANCER AWARENESS DAY".


TEAL POWER! Be a soldier in this war against Gynecologic Cancers.Please take a stand, assemble together in a TEAL UNION FOR THE GREATER GOOD!

Teal Toes- Raising Ovarian Cancer Awareness


Loehmann's Fashion Funds Hope- Ovarian Cancer Research Fund


Loehmann's Fashion Funds Hope
September 24, 2009 Fashion Funds Hope

L'Oreal Ovarian Cancer Awareness Week


L'Oreal Ovarian Cancer Awareness Week
September 14 - 20, 2009


Color Of Hope

NYTW Presents " I got Sick Then Got Better"



NYTW Presents" I GOT SICK THEN I GOT BETTER" Written and performed by Jenny Allen Directed by James Lapine & Darren Katz
Photo by Jayne Wexler
Limited EngagementStarting September 14, 2009 for four consecutive Mondays only.Special Benefit Opening Nightfor The Ovarian Cancer Research Fund more information


"I Got Sick Then I Got Better" is a wrenching comic riff on one woman's adventures after falling down the medical rabbit hole. Diagnosed with andtreated for ovarian cancer in 2005, writer and performer Jenny Allen (The New Yorker, The New York Times) tells her story of the harrowing tailspin she took following her diagnosis, combining biting humor with searing emotion in a witty, bittersweet monologue that limns the personal and family collateral damage a life-threatening illness brings.


September 26, 2009 Fashion Fights Ovarian Cancer_ Sandy Rollman


Sandy Rollman ~September 26, 2009 Fashion Fights Ovarian CancerDinner, live and silent auction and fashions by top designer Pamela Dennis. Sponsored by Carlino’s; Shops at Liberty Place; 1625 Chestnut St. Philadelphia, PA 19103. 7 PM. Honoring George Coukos, MD, PhD, Associate Chief, Division of Gynecologic Oncology Director, Ovarian Cancer Research Center University of Pennsylvania with the Angela Carlino Excellence in Ovarian Cancer Research/Care Award.The Premiere of an Official Ovarian Cancer T-shirt designed by Pamela Dennis.

Teal Walk- September 12th, 2009 Prospect Park, Brooklyn, NY


Saturday, September 12, 2009
Prospect Park, Brooklyn, New York

A non-competitive 5K event.

September is National Ovarian Cancer awareness month.

Please join us on Saturday, September 12, 2009 for Tell Every Amazing Lady About Ovarian Cancer’s first annual T.E.A.L. Walk in Brooklyn’s Prospect Park. Bring all of your friends and family members and help us make a difference! All proceeds from this year’s T.E.A.L. Walk will be donated to The Ovarian Cancer Research Fund (OCRF)

OCRF~ GET INVOLVED NOW and we'll donate 22,000


On September 1, 2009, join Seventh Generation to save women's lives. For every person that registers, $1 will be donated to the OCRF until we hit $22,000 (each year 22,000 women are diagnosed with the disease).

Join us at our 3rd Annual 3 K Walk to "Break the Silence" for Ovarian Cancer

Don't miss being part of the biggest Ovarian Cancer Day on LI it's just 25 days away.........

Join us at our 3rd Annual 3 K Walk to "Break the Silence" for Ovarian Cancer

September 26, 2009
Eisenhower Park- Field 5, East Meadow NY

Please see the attached PDF for your convenience.
If you prefer please visit our walk page at:

http://nocc.kintera.org/nyli

We ask you to forward this email to your family / friends / Co-workers. If you have any questions or concerns about this day please do not hesitate to contact us at 631-672-2027 or nyli.nocc@ovarian.org
Liz Pittelko
President

Long Island ChapterNational Ovarian Cancer Coalition
PO Box 20666
Huntington Station, NY 11746631-672-2027
nyli.nocc@ovarian.org
www.ovarian.org

50 x 50 Campaign ~ September 20, 2009

See Jenn Tri to raise $100,000 by competing in triathlons in all 50 states by the age of 50.

If ever there was a time to be in Washington, D.C, it's NOW!


The 12th annual Ovarian Cancer National Alliance

“Celebration of Life” Conference


July 6th- 9th, 2009


Omni Shoreham Hotel in Washington, D.C.

Ovarian Cancer Biomarker Research Act

Ovarian Cancer Biomarker Bill Will be Introduced in the House of Representatives

Ovarian Cancer Biomarker Research ActBill # S.2569


Original Sponsor:Barbara Boxer (D-CA)Cosponsor Total: 16(last sponsor added 06/23/2008) 14 Democrats 1 Independents 1 Republicans


About This Legislation:A bill to amend the Public Health Service Act to authorize the Director of the National Cancer Institute to make grants for the discovery and validation of biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer.

Urge your Representative to Sign On to H.R. 1230


Grassroots Action Center


Urge your Representative to Sign On to H.R. 1230


On February 26, 2009, Representative Doris O. Matsui (D-CA) formally introduced the Bone Marrow Failure Disease Research and Treatment Act of 2009 (H.R. 1230). This legislation would bring together the resources of several federal agencies to advance our understanding of and treatments for aplastic anemia, myelodysplastic syndromes, and PNH. We need your support now

Drug combo helps with repeat cancers in women

Jon Lovitz Supports OCRF With New Comedy Club Opening


Lovitz will perform opening night at The Jon Lovitz Comedy Club, located on CityWalk at Universal Studios Hollywood. The club features a Hawaiian beach motif, complete with sand dunes, palm trees, and delicious food for club-goers, and boasts a three-story, 400 seat capacity in which to enjoy live music and stand-up comedy.


A long-time friend of Faith Kates Kogan, president of OCRF's Board of Directors and founder of NEXT Model Management, Lovitz has participated in several of OCRF's signature events throughout the years, including Super Saturday LA. NEXT Model Management will co-host the gala benefit.


"It feels good to be able to do something like that," Lovitz says of his support for OCRF. Referencing Gilda Radner and Madeline Kahn, he recognizes that many great women in comedy have been taken too soon from cancer. "The whole point is to raise money for a cure and also for early detection."


OCRF thanks Jon Lovitz for his ongoing support, and for all that he has done to spread awareness and raise funds to continue the progression of ovarian cancer research. We wish him the best of luck in his endeavor, and encourage everyone to stop by the club to enjoy a great night of entertainment.

6th Annual Marie S. Franck " Footsteps toward Hope Ovarian Cancer Walk"

You can make a difference in the fight against ovarian cancer. Walk in memory or walk for a survivor at the 6th annual Marie S. Franck Foosteps Toward Hope Ovarian Cancer Walk on May 2, 2009 at 8:30am at the Jones Beach Boardwalk, parking field #5.

All proceeds will benefit the Rosewell Park Cancer Institute in Buffalo. Help them break the $100,000 mark with this year's donations!

To sign up, call Sister Suzanne at St. Joseph's College in Patchogue at (631) 447-6581.

March 26th, 2009 Loehmann's Fashion Funs Hope to benefit the OCRF-Ovarian Cancer Research Fund


On Thursday, March 26th, fashion-savvy, budget-minded shoppers can support Ovarian cancer research while receiving special savings on leading designer apparel for one day only, at any of the sixty-four Loehmann's stores across the country.


As part of its chain-wide Fashion Funds Hope in-store event, Loehmann's will offer an additional 15% discount above its standard 30-65% savings to any customer who donates five dollars to the Ovarian Cancer Research Fund (OCRF).


In addition, Loehmann's will make a contribution to OCRF of 5% of total purchases by donors.Loehmann's customers will be able to pick up information about ovarian cancer, from risk factors and symptoms to the three programs run by OCRF, at tables set up inside the stores that day.

Doo- Wop Concert for Ovarian Cancer


March 26th, 2009 Loehmann's Store's host Fasion Funds Hope to benefit the OCRF

OCRF is pleased to announce that on March 26, Loehmann’s stores will host Fashion Funds Hope, a fun-filled day of shopping and savings to benefit the Ovarian Cancer Research Fund.

We invite you to help make this day a success by volunteering to represent OCRF at a Loehmann’s store location near you.

As a volunteer, you can help disseminate OCRF literature and encourage shoppers to donate in support of life-saving ovarian cancer research. Participate in Fashion Funds Hope, and organize a team of family and friends to help raise funds and awareness for ovarian cancer. With your help, we will make this day a nationwide success!

Upcoming Lecture " Advances in Gyn Oncology" given by Dr. Jeanine Villella

Dr. Jeannine Villella, Attending Physician, Division of Gyn Oncology at Winthrop University Hospital will be giving an evening lecture to the community on March 12, 2009 on the topic “Advances in Gyn Oncology.”

If interested in attending please contact : Julie Mischo RN, MSNCancer Care Coordinator
Winthrop University Hospital

Phone 516-663-4637

Women's cancer outcomes improved by surgical evaluation

Vascular Experts Call for Increased Awareness of Growing Problem of Lymphedema

Committee approves bill on ovarian cancer awareness

Ovarian cancer: The search for an accurate screening technique


Women's cancer outcomes improved by surgical evaluation

SGO: Few Ovarian Cancer Patients Tolerate Intraperitoneal Regimen

OCRF and GCF fund new ovarian cancer symptoms study

OCRF and GCF fund new ovarian cancer symptoms study

Study hopes to improve symptom recognition

New York (February 5, 2009) --- Today, the Ovarian Cancer Research Fund (OCRF), in partnership with the Gynecologic Cancer Foundation (GCF), announced that Barbara Goff, M.D., Director of Gynecologic Oncology at the University of Washington, has been named to lead the OCRF Ovarian Cancer Symptoms Study. The award was presented by OCRF Scientific Advisory Board Vice-Chair, Carmel Cohen, M.D., at the Society of Gynecologic Oncologists 40th Annual Meeting on Women's Cancer™ in San Antonio, Texas.

The study builds on an original symptoms study conducted by Dr. Goff which formed the basis for the first national Consensus Statement on Ovarian Cancer Symptoms, issued in 2007. The grant will allow researchers to forge ahead in their efforts to develop a systematic symptoms screening process for ovarian cancer.

Dr. Goff, a leading expert in gynecologic cancer research, was chosen to receive the grant, which will be awarded over three years. She was selected by a committee assembled by the GCF and chaired by Thomas Herzog, M.D. The selection committee also included three members of the OCRF Scientific Advisory Committee.

Prior to the development of the Consensus Statement on Ovarian Cancer Symptoms, ovarian cancer was often referred to as the "silent killer." Dr. Goff's research led to an evidence-based list of symptoms associated with ovarian cancer. When ovarian cancer, the deadliest reproductive cancer, is detected early, it is 90% curable The three-year symptoms study will pilot a method of systematically collecting symptom information with the hope that a symptoms index can be developed for broad use in early ovarian cancer detection.

Dr. Cohen is Professor of Obstetrics and Gynecology at Mount Sinai Medical Center in New York City. "Based on early data, patients with seemingly early disease are included among those who present with new and otherwise unexplained symptoms," Dr. Cohen noted. "While this may not be typical of early ovarian cancer, attention to the symptom complex may still serve as 'early detection' and thereby allow better opportunity for disease control in a segment of the population who develop ovarian cancer. We look forward to the possibility that this study will answer this question."

Dr. Goff has spent years researching and writing about ovarian cancer and the discovery of an early detection method. A diagnostic tool for early detection is crucial since there is a significant difference in cure rates if ovarian cancer is found early. "Through the continuation of this vital research, we aim to debunk the myth that ovarian cancer is a 'silent disease,' and empower both physicians and women to be better equipped to recognize symptoms in their earliest stage," Dr. Goff said. "Huge progress has been made, and now it's time to take the next step."

###
The Ovarian Cancer Research Fund is a 501(c) 3 not-for-profit organization founded in 1994 with a mission to fund research to find a method of early detection and ultimately a cure for ovarian cancer. OCRF is the leading independent agency dedicated to advancing ovarian cancer research in the United States. For more information, visit www.ocrf.org.

The Gynecologic Cancer Foundation (GCF), founded by the Society of Gynecologic Oncologists in 1991, is a 501(c) 3 not-for-profit organization whose mission is to ensure public awareness of gynecologic cancer prevention, early diagnosis and proper treatment. In addition, the Foundation supports research and training related to gynecologic cancers. GCF advances this mission by increasing public and private funds that aid in the development and implementation of programs to meet these goals.

Sixth International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

Sixth International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

The Ritz-Carlton New York, Battery ParkNew York, NYMar 20-21, 2009

Ovarian Cancer Researchers At Yale Win Millions In Federal And Foundation Grants


Sood Makes Breakthrough in Ovarian Cancer Research




HOUSTON, TX - In a major breakthrough, which can dramatically increase survival chances of ovarian cancer patients, an Indian American scientist has identified two proteins whose presence increases the median survival rate by 11 years in patients with the disease.

A study of nearly 250 ovarian cancer patients by Dr Anil Sood, MD, Professor in the departments of Gynecologic Oncology and Cancer Biology at M D Anderson, along with other researchers, found that woman with high levels of two proteins named Dicer and Drosha in their tumor cells had a median survival rate of 11 years. While, in patients with low levels of one or both proteins about 40 percent of those studied had a median survival of less than three years.

Sood’s discovery marks a significant advance for an emerging area of basic science called RNA interference, which one day may transform medicine.

“What’s important is that Dicer and Drosha are critical to the process of RNA interference,” Anil Sood said.

read more: http://www.indiajournal.com/pages/event.php?id=5786

NCI- Animation/Video on Proteomics

Long Island Press Cover Story- " Disappearing Doctors"


Force upcoming " Chat-a-thon" Jan 29 th-Jan 31st


Date: January 29-January 31, 2009
Time : One minute after midnight on January 29 to one minute before midnight on January 31.
Location: The FORCE Chat Room
Check out our regular scheduled chats and come back on the 29th!
Visit our chat room now

CancerCare-Medical Update on Ovarian Cancer- February 26, 2009



Medical Update on Ovarian Cancer
Thursday, February 26, 2008
1:30 - 2:30 p.m.


This is a free Telephone Education Workshop for women living with ovarian
cancer, their families, friends and health care professionals provided by
CancerCare Connect where leading experts in oncology provide the most up
to date information over the telephone. Speakers for this workshop include
Carolyn D. Runowicz, MD, Ilana Cass, MD, and Patricia Spicer, MSW.

Workshop Topics:
Overview of Ovarian Cancer
Staging
Current Standard of Care
New Treatment Approaches
The Important Role of Clinical Trials
Controlling Symptoms and Pain
Communicating with Your Health Care Team
Quality-of-Life Concerns
Questions and Answers

How to register:
Call CancerCare at 1-800-813-HOPE(4673)
or
on-line using the following link: Medical Update on Ovarian Cancer

Juliana Marchesano, BSW, MPH Intern
Ovarian Cancer Program
NYSDOH Cancer Services Program
(518) 402-9065

Women's Cancer Network- Cancer Risk Assessment Survey

NCCN Receives $4 Million Oncology Research Grant from Wyeth

Kathy Bates reveals her triumph over ovarian cancer


Obesity may raise risk of ovarian cancer


.Big Health Insurer Agrees to Update Its Fee Data

Health insurer accused of overcharging millions

Biotech Firm's Tests Detect Predisposition To Cancer

Elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells.

"Malignant" uterine perivascular epithelioid cell tumor, pelvic lymph node lymphangioleiomyomatosis, and gynecological pecomatosis in a patient with t

Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.

Dicer, Drosha, and outcomes in patients with ovarian cancer.

Functional significance of VEGFR-2 on ovarian cancer cells.

Identification of novel peptide ligands for the cancer-specific receptor mutation EFGRvIII using a mixture-based synthetic combinatorial library.

Nelfinavir induces the unfolded protein response in ovarian cancer cells, resulting in ER vacuolization, cell cycle retardation and apoptosis.

14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients.

Ovarian carcinoma as a surrogate tumor for lung adenocarcinomas in evaluating the chemo-stability of a gene expression signature.

A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.

Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer

Inhibition of multi-drug resistance of ovarian carcinoma by small interfering RNA targeting to MRP2 gene.


Ovarian carcinoma as a surrogate tumor for lung adenocarcinomas in evaluating the chemo-stability of a gene expression signature.

Preclinical assessment of anti-cancer drugs by using RP215 monoclonal antibody.

Chromosomes 6 and 18 induce neoplastic suppression in epithelial ovarian cancer cells.

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers.

Tamoxifen prevents premalignant changes of breast, but not ovarian, cancer in rats at high risk for both diseases.

Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?

A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.

Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.

Functional significance of VEGFR-2 on ovarian cancer cells.

The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer.

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.

IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype.

A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines.

Enhanced complement resistance in drug-selected P-glycoprotein expressing multi-drug-resistant ovarian carcinoma cells.

YKL-40 tissue expression andplasma levels in patients with ovarian cancer.

Oregovomab Maintenance Monoimmunotherapy Does Not Improve Outcomes in Advanced Ovarian Cancer

Cancer: The Road to Amiens

An Indomitable Spirit Gets Help With Medical Benefits

Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role

'Normal lifespan' is goal in ovarian cancer screening study, Ian Jacobs tells HOW group

Stem Cells Could Be Used For Personalized Cancer Treatment

Anticipation in Lynch Syndrome: Still Waiting for the Answer

Documentary on Cancer Biology-video


The Immune System and Cancer

It was not always clear to scientists that the immune system played a role in preventing and combating cancer. This idea was proposed in 1957, but the scientific evidence at the time only seemed to indicate that the immune system protected against pathogens like viruses and bacteria, but not against abnormal body cells like cancer cells. Researchers and doctors in the late 1900s noticed, however, that people with extremely weak or nonexistent immune systems had a greater risk of developing cancer than the average person. In addition, researchers have since noticed that patients with immune cells present in their tumors have a better prognosis than patients without immune cells in their tumors.

Immunosurveillance is a term used to describe the action of the immune cells, including T cells, as they move through the body and look for any abnormalities. When cells become mutated, they may appear to the immune cells as abnormal. The body then recognizes them as non-self or foreign. By eliminating cells that have become abnormal, the immune system helps to protect against cancer. However, if the cells mutate enough so that they are able to escape the surveillance mechanisms of the immune system, they may continue to reproduce as cancer cells. The process is a complex version of 'hide and seek' with major consequences.

As described in the previous pages, T cells recognize peptide antigens 'presented' on their cell surface. If pre-cancerous cells present abnormal proteins T cells will recognize these cells as abnormal. Conversely, pre-cancerous cells that the immune system does not recognize as abnormal, or is unable to kill, will survive and may proliferate to form a tumor.

There are various mechanisms that tumor cells may use to get around the immune defenses of the body. Many cancers produce chemical messengers that inhibit the actions of immune cells. Other cancers have defects in the way that antigens are presented on their cell surface. Other immune cells, called natural killer (NK) cells, play a special role in this case, however, because they notice when body cells no longer have present specific 'self' proteins on their surface and kill the abnormal cells. Additionally, some tumors grow in locations such as the eyes or brain, which are not regularly patrolled by immune cells.

The main goal of immunotherapy and cancer vaccines is to provide the immune system with the signals that it needs to recognize the cancer cells as abnormal. If successful, these strategies may allow the body to recognize and destroy cancer cells, even those that have been able to form a tumor.

For more-----http://www.cancerquest.org/index.cfm?page=4903

New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact

Carol's Cause Presents the Annual " Peaches 'N Cream Gala"

Carol’s Cause
PRESENTS
THE ANNUAL PEACHES ‘N CREAM GALA
to benefit gynecologic cancer research

HONORING

HON. ESTER BIVONA
Receiver of Taxes, Town of Huntington and an ovarian cancer survivor

EVA CHALAS MD, FACOG, FACS
Professor and Vice-Chair
Department of Obstetrics and Gynecology at Winthrop-University Hospital

MICHELLE DI BENEDETTO
Director Community Relations, Long Island, Citi and an ovarian cancer survivor

BARBARA ROSS LEE DO, FACOFP
VP for Health Sciences and Medical Affairs
NY College of Osteopathic Medicine, NYIT


Monday, November 17, 2008

Cocktails in the Library Room – 6:00 PM

Dinner, reception immediately following

Black tie optional

Westbury Manor
Jericho Turnpike
Westbury, New York

For ticket and journal ad information call 516 873 1267 (Joe) or 516 342 5751 (Marc)

Carol’s Cause is a 501 (c) (3) organization.
All donations are tax deductible to the extent allowable by law.

Carcinoma of the Lower Uterine Segment: A Newly Described Association With Lynch Syndrome

Physicians' Experiences With BRCA1/2 Testing in Community Settings

Introduction to Oxidation and Anti-oxidants-From Cancer Quest

Oxidation is the chemical process that causes metal to rust and apples to turn brown. When this same process happens inside your body, it can harm cells and tissues. Primarily, molecules called 'free radicals' are responsible for this oxidative damage. Free radicals can be contained in (or induced to form by) a variety of things including tobacco smoke, radiation (like sunlight or x-rays) and even the normal functioning of the human body. These molecules have properties that allow them to quickly interact with, and alter, other molecules. Targets of free radicals include DNA, lipids and proteins. These interactions cause severe problems for cells and ultimately the entire body.

Antioxidants refer to molecules that, as the name suggests, counteract oxidation. Examples of dietary antioxidants include vitamins C and E. Antioxidants are able to interact with and neutralize free radicals in vitro , improve health and prolong life in animals , and many studies are underway to investigate the potential of these compounds to prevent cancer in humans.

Resistance to Cancer Treatment

The Innate Immune System

Specific Inhibitors

Ovarian Cancer Awareness Stamp--PLEASE SIGN IN MEMORY OF Carolyn Benivegna

Together we can make an OvCa stamp a reality. We have been requesting an ovarian cancer awareness postage stamp annually since 2001 and need your help. If you would like to support our goals, please sign our online petition. We will submit a request to the U.S. Postal Service along with the signatures that share in our quest to make this a reality.

In memory of Carolyn Benivegna, survivors, family and friends of those touched by ovarian cancer, please click on the link and help us send our message through the U. S. Postal Service. http://www.ipetitions.com/petition/ovca2008/

Thank you.
Ovacome
www.ovacome.us
ovcasurvivor@verizon.net

EVERYTHING YOU ALWAYS WANTED TO KNOW…


EVERYTHING YOU ALWAYS WANTED TO KNOW…ABOUT COMBINING WORK AND CANCER TREATMENT


Please save-the-date for the upcoming Balancing Cancer and Careers Seminar in Knoxville.


When:Wednesday, October 15, 20085:30 PM-7:30 PM


Where:Women's Basketball Hall of Fame700 Hall of Fame DriveKnoxville, TN 37915


What:A FREE interactive, educational seminar featuring expert advice and personal success stories.


Who:• Kate Sweeney, Executive Director, Cancer and Careers, will providepractical advice and concrete solutions for employeesaffected by cancer.• Holly Warlick, Breast Cancer Advocate and Associate Head Coach of the University of Tennessee’s Women’s Basketball Team, will appear as a guest speaker.• A local breast cancer survivor will share her experience navigating her career and her cancer treatment.• A noted local oncologist will discuss the value of working through treatment and a legal expert will address patient rights in the workplace.


RSVP:(865) 523-6126 or scondon@ywcaknox.com


The Balancing Cancer and Careers Seminar is a collaboration between Cancer and Careers, Roche, The YWCA of Knoxville and The Wellness Community of East Tennessee.

The L'Oreal Paris Hope Necklace


Simply Stunning.


The L'Oreal Paris Hope Necklace is a simple way for women everywhere to visibly and tangibly help in the fight against one of the most deadly women's cancers.


The necklace was designed by 2008 Swarovski Award for Accessory Design recipient Philip Crangi and features a double eternity ring design of cubic zirconia set in sterling silver.


One ring is worn for remembrance and one ring is worn as a symbol of hope for the future.


The two eternity rings are free floating and suspended from an 18" rolo link chain. Each ring is comprised of 21 channel set, 2mm brilliant cubic zirconias.


This necklace normally retails for $99 but is being offered for only $29.95 (plus $5.95 s&h) to support ongoing research to defeat this dreadful disease. Net profits (five dollars per sale) will benefit the Ovarian Cancer Research Fund.


L'Oreal Paris has proudly supported the Ovarian Cancer Research Fund since 1997 and has helped to raise over $14 million to find life-saving research. For more information, visit http://www.lorealcolorofhope.com/

Attorney/Ovarian Cancer Survivor gets probation and is suspended for Contempt for refusing to provide documentation from her doctor.

Attorney/Ovarian Cancer Survivor gets probation and is suspended for Contempt for refusing to provide documentation from her doctor.

She contended that her tardiness was largely the product of medical issues stemming from ovarian cancer; the "contempt," she said, was only the typical back-and-forth between an attorney and a judge. She was guilty only of "disagreeing with a judge."

Pollack called herself "a whistle-blower who defended whistle-blowers," who was now the subject of a broad, illegal retaliatory scheme.

"The court proceeding today could only be described as criminal," Pollack said. "Am I not a whistle-blower, judge? Am I not a whistle-blower?"

"You may be the world's best whistle-blower," Ross answered, "but it isn't relevant."

The judge ordered two years' probation and a 45-day suspension, but declined to fine Pollack.
Kellman could not be reached for comment.


Assistant U.S. Attorney Monica Ryan represented the prosecution. She declined to comment.
Asked outside the courtroom if she intended to appeal, Pollack answered, "Yes, absolutely -- the entire thing."


Ruth was diagnosed in 2003 with Ovarian Cancer. She suffers from lymphedema in both legs and feet which from time to time requires that she rest and elevate her legs to recover. Ruth is a civil rights attorney and have been a trial lawyer for 25 years.

Ruth has had a number of male judges demand that she supply them with a "note" from her doctor explaining why she need a day of rest during a multi week trial, an adjournment of a conference due to the sudden swelling of her legs and feet, etc.

Ruth has had her primary care doctor take time from her busy schedule to prepare such letters through the years.

Sadly, her word as an attorney and officer of the court is not good enough.

Ruth refused one judge, insulted and appalled at the cruelty of this requirement. She decided to take a stand so that others like her would be treated with the respect they are due.

Teal Tuesday, September 23rd, 2008. National Ovarian Cancer Awareness Day

Press Release---
For Immediate Release

Teal Tuesday, September 23rd, 2008. National Ovarian Cancer Awareness Day.

Khrissy Lupinacci from LI OCEANS Inc (Long Island Ovarian Cancer Education Advocacy Network & Support) launches a Nationwide Public Awareness Campaign calling September 23rd, the 3rd Tuesday of September “ Teal Tuesday”. Our goal is to promote public education and much needed awareness of the deadliest form of Gynecologic Cancer called Ovarian Cancer. Ovarian Cancer claims the lives of over 22,000 women each year, this year alone over 15,000 women will be diagnosed with this deadly disease.

Khrissy Lupinacci (a 6 year survivor of Ovarian Cancer and one of the founding members of LI OCEANS Inc) said, “September is National Ovarian Cancer Awareness month.” “ It is our hope that “ Teal Tuesday ” inspires millions of people to adopt this day to raise awareness of this deadly disease. “ We are in need of soldiers, it will take an army to fight this fight against Ovarian Cancer “ said Khrissy. “ We are in need of heros” our greatest asset in this fight against ovarian cancer is our caring and compassionate community at large.” We hope that individuals, busineses and corporations join us in our plight to save lives. “We ask for national and local partnerships to help execute this initiative and support this campaign, making the 3rd Tuesday of September “ Teal Tuesday”. We hope this campaign inspires individuals to join us in our fight and encourages grassroots activities within their own communities to “ think teal, talk teal, wear teal, save lives!

Saving lives, each and everyone of us has the power to save lives, to date there is not an effective nor 100 % accurate early detection test for Ovarian Cancer. We know that early detection can save lives, however, with the lack of an early screening test and lack of Ovarian Cancer Awareness, we are left with but one vital tool, our voice. Together we can educate one another and create much needed awareness. A Pap test does not detect Ovarian Cancer. You don’t need to be personally affected by Ovarian Cancer to help in the fight to educate, advocate and create awareness, you simply need to care. Educate yourself about the signs and symptons of Ovarian Cancer, call or visit your local or National Ovarian Cancer organization, arm yourself with education and awareness of the signs, symptoms and risk factors of the disease, spread the news.

Sadly the majority, 75 percent of women are diagnosed in the later stages of Ovarian Cancer; the five –year survival is only 30 percent.
LI OCEANS INC believes one is too many; we must educate and advocate so to eradicate this deadly disease. Please join us in saving lives.

We ask locally and nationally that others join us in our plight to create much needed awareness of this ruthless and relentless killer of women. On Tuesday September 23rd, please wear teal! Wear teal in honor of the thousands of beautiful women that are battling the disease, wear teal in memory of the precious lives of those who have lost their battle to this disease. Wear Teal to help raise public awareness of the often overlooked and unrecognized signs and symptoms of this disease. Wear Teal because you care about the thousands of Grandmothers, Mothers, Sisters and Daughters that will be diagnosed with Ovarian Cancer this year. Wear teal for the 22,000 women that will die from Ovarian Cancer this year. Wear teal, help save lives.

Teal Tuesday, the initiative to launch a national public awareness campaign to save hundreds, thousands of women from Ovarian Cancer. On September 23rd, Teal Tuesday please wear teal; tie teal ribbons or teal balloons within your community, place of business, office or front lawn. Encourage hospitals, businesses, companies, schools, churches, synagogues, restaurants, stores, corporations, government offices, employees and co-workers to wear teal. Contact newspapers, radio, and television. Encourage Members of Congress to participate & adopt this as an annual campaign. “ Our goal is that every woman is educated and made aware of the signs, symptoms and risk factors of Ovarian Cancer.” Said, Khrissy Lupinacci.

The Kaleidoscope of Hope Foundation

KALEIDOSCOPE OF HOPE’S ANNUAL WALKATHONS – 2008
MORRIS – Sunday, September 14 LYNDHURST – Sunday, September 21AVON – Saturday, September 27

For one morning and 1, 3 or 5 miles, you have the opportunity to dramatically impact the lives of women and their families affected by ovarian cancer. By participating in our 9th Annual Walkathon Events you help support ovarian cancer research and early detection programs.

Watch Stand Up to Cancer TONIGHT September 5th, 2008

TUNE IN TONIGHT SEPTEMBER 5TH 8PM ET/PT

STAND UP TO CANCER

Over 50 of the most renowned personalities in TV, film, sports and music will come together to make history. In an unprecedented television event, NBC, ABC, and CBS will simultaneously devote 1 hour of commercial-free prime time to raise funds for the fight against cancer.


A spectacular line up of talent including Jennifer Aniston, James Taylor, Scarlett Johansson, Meryl Streep, David Cook, Christina Applegate, Lance Armstrong, Jack Black, Kirsten Dunst, Charles Barkley, America Ferrera, Halle Berry, Hilary Swank, Forrest Whitaker, Jimmy Fallon, Keanu Reeves * will make personal appearances on the show. These celebrities and more will educate you, move you and entertain you. They will also be on hand to answer your calls in the celebrity phone bank.


ONE NIGHT ONE STAGE

The premiere TV performance of “Just Stand Up” – the star studded charitable single in support of Stand Up To Cancer will be performed by legendary recording artists Mariah Carey, Beyonce, Mary J. Blige, Rihanna, Fergie, Sheryl Crow, Miley Cyrus, Melissa Etheridge, Ashanti, Natasha Bedingfield, Keyshia Cole, Ciara, Leona Lewis, LeAnn Rimes, and Carrie Underwood.


Don’t miss out!
Tune in September 5th at 8pm on ABC, NBC and CBS!

OVARIAN CANCER SURVIVORS GROUP DONATES $25,000 TO SBUMC

OVARIAN CANCER SURVIVORS GROUP DONATES $25,000 TO SBUMC FOR GYNECOLOGIC CANCER RESEARCH INITIATIVES

Gift Coincides With National Ovarian Cancer Awareness Month

STONY BROOK, N.Y., September 2, 2008 – Long Island OCEANS (Ovarian Cancer Education Advocacy Network & Support), an organization made up of gynecologic cancer survivors, donated $25,000 to Stony Brook University Medical Center to support research on the early detection and treatment of ovarian cancer and other gynecologic cancers. SBUMC cancer researchers have received continued support from L.I. OCEANS, including a grant for $25,000 in 2006.

Ovarian cancer is the most deadly form of gynecologic cancer. According to the American Cancer Society, ovarian cancer claims the lives of more than 22,000 each year, and 15,000 women are diagnosed with the disease annually. The White House has declared September National Ovarian Cancer Awareness Month, and the Gynecologic Cancer Foundation calls September National Gynecologic Cancer Awareness Month.

“The search for better and more accurate diagnostics for early detection of gynecologic cancers, particularly for ovarian cancer, is central to our research,” says Michael L. Pearl, M.D., Director, Division of Gynecologic Oncology at SBUMC. “The grant from Long Island OCEANS will help further several research initiatives,” adds Dr. Pearl, emphasizing that because symptoms of ovarian cancer often do not occur until the disease is advanced, many women are not diagnosed early enough to help control or cure disease.

The goal of L.I. OCEANS is to create awareness among women regarding the early warning signs and symptoms of gynecologic cancers. The network provides support, resources, and education for women diagnosed with gynecologic cancers, as well as support for the advancement of disease research. L.I. OCEANS is promoting “Teal Tuesday,” September 23, as National Ovarian Cancer Awareness Day. The organization is appealing for people to wear teal in honor of the thousands of lives who have been touched by the disease.

The Division of Gynecologic Oncology at SBUMC is within the Department of Obstetrics, Gynecology and Reproductive Medicine. The Division provides comprehensive examinations, diagnostic services, and treatment for women with all forms of gynecologic cancer. Research is a major component of the Division. Patient services are provided at SBUMC, the Stony Brook University Cancer Center outpatient facility, and at Long Island Gynecologic Oncologists, P.C., with offices in Smithtown and Mineola.



Caption: Stony Brook University Medical Center received $25,000 from L.I. OCEANS (Ovarian Cancer Education Advocacy Network & Support) for gynecologic cancer research. Pictured from left: Eileen Tobin, OCEANS member; Denise Reilly, Administrator, Ambulatory Cancer Services, SBUMC; Theodore Gabig, M.D., Interim Director, Stony Brook University Cancer Center; Khrissy Lupinacci, an OCEANS founding member; Michael L. Pearl, M.D., Director, Division of Gynecologic Oncology, SBUMC; Chris Reynolds, OCEANS member; and Marylou Stewart, OCEANS founding member and Supervisor, Medical Photography, SBUMC. Credit: Jeanne Neville, Stony Brook University Media Services
******************************************************************************


Greg Filiano Media Relations Manager, School of MedicineStony Brook University Medical CenterLevel 5, Suite 9, Rm. 429Stony Brook, NY 11794-7538631-444-9343 gfiliano@notes.cc.sunysb.eduwww.stonybrook.edu/news

NOCC Walk- Long Island Chapter- September 20th, 2008


SAVE THE DATE: NOCC Long Island chapter walk - September 20, 2008 - Wantagh Park, Wantagh, NY.

For More info contact Linda Rosen ( NY, Long Island NOCC Chapter)
Phone: 631-672-2027; nyli.nocc@ovarian.org

Upcoming Long Island Event

Upcoming Long Island Event
DOO-WOP CONCERT FOR OVARIAN CANCER